25 May 2013
Keywords: ec, reinstates, roche, viracept, european, commission, reinstated
Article | 29 October 2007
The European Commission has reinstated marketing clearance for Roche's HIV drug Viracept (nelfinavir). The Swiss firm said that it welcomed
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
29 October 2007
24 May 2013
© 2013 thepharmaletter.com